- Home
- AENT vs CATX Comparison
AENT vs CATX Comparison
Compare AENT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AENT
- CATX
- Stock Information
- Founded
- AENT 1990
- CATX 1983
- Country
- AENT United States
- CATX United States
- Employees
- AENT N/A
- CATX N/A
- Industry
- AENT Durable Goods
- CATX Medical/Dental Instruments
- Sector
- AENT Consumer Discretionary
- CATX Health Care
- Exchange
- AENT Nasdaq
- CATX Nasdaq
- Market Cap
- AENT 148.0M
- CATX 133.3M
- IPO Year
- AENT N/A
- CATX N/A
- Fundamental
- Price
- AENT $3.09
- CATX $2.31
- Analyst Decision
- AENT
- CATX Strong Buy
- Analyst Count
- AENT 0
- CATX 10
- Target Price
- AENT N/A
- CATX $13.89
- AVG Volume (30 Days)
- AENT 56.2K
- CATX 971.7K
- Earning Date
- AENT 05-08-2025
- CATX 05-12-2025
- Dividend Yield
- AENT N/A
- CATX N/A
- EPS Growth
- AENT N/A
- CATX N/A
- EPS
- AENT 0.13
- CATX N/A
- Revenue
- AENT $1,070,804,000.00
- CATX $1,454,000.00
- Revenue This Year
- AENT $4.77
- CATX N/A
- Revenue Next Year
- AENT N/A
- CATX $1.15
- P/E Ratio
- AENT $22.42
- CATX N/A
- Revenue Growth
- AENT N/A
- CATX 1.40
- 52 Week Low
- AENT $1.10
- CATX $1.60
- 52 Week High
- AENT $11.57
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- AENT 45.51
- CATX 55.20
- Support Level
- AENT $2.66
- CATX $1.75
- Resistance Level
- AENT $3.20
- CATX $2.11
- Average True Range (ATR)
- AENT 0.49
- CATX 0.20
- MACD
- AENT 0.05
- CATX 0.06
- Stochastic Oscillator
- AENT 69.29
- CATX 87.65
About AENT Alliance Entertainment Holding Corporation
Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.